FindTrial
Sign In

A study to evaluate clinical characteristics of Chinese patients with T1 non-small cell lung cancer complicated with lymph metastases

A multi-centre real-world observational study to evaluate clinical characteristics of Chinese patients with T1 non-small cell lung cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014728
Enrollment
Unknown
Registered
2018-01-31
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Case series:Surgeries

Sponsors

Jiangsu Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with surgeries who were enrolled in clinics from 2015 to 2017; 2. Diagnosed T1 patients after surgeries; 3. Pathologically diagnosed non-small cell lung cancer.

Exclusion criteria

Exclusion criteria: Patients with cancer treatments before surgeries (including chemotherapies, radiotherapies, biological therapies, intervention therapies).

Design outcomes

Primary

MeasureTime frame
Percentage of patients with lymph metastases;—

Secondary

MeasureTime frame
Percentage of N0, N1, N2, N3 patients in the target population;—

Countries

China

Contacts

Public ContactLin Xu

Jiangsu Cancer Hospital

xulin83@vip.sina.com+86 13605168383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026